Clinical trial
Retrospective Analysis of Patients Treated With Bevacizumab in GHPSJ Intraperitoneal for the Treatment of Refractory Malignant Ascites
NCT02891369 is registered in ClinicalTrials.gov with Fondation Hôpital Saint-Joseph as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retrospective Analysis of Patients Treated With Bevacizumab in GHPSJ Intraperitoneal for the Treatment of Refractory Malignant Ascites
- Lead sponsor
- Fondation Hôpital Saint-Joseph
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2015
- Completion date
- May 31, 2015
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
refractory malignant ascites